BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 17984175)

  • 1. Therapeutic antibodies targeting angiomotin inhibit angiogenesis in vivo.
    Levchenko T; Veitonmäki N; Lundkvist A; Gerhardt H; Ming Y; Berggren K; Kvanta A; Carlsson R; Holmgren L
    FASEB J; 2008 Mar; 22(3):880-9. PubMed ID: 17984175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiomotin regulates endothelial cell migration during embryonic angiogenesis.
    Aase K; Ernkvist M; Ebarasi L; Jakobsson L; Majumdar A; Yi C; Birot O; Ming Y; Kvanta A; Edholm D; Aspenström P; Kissil J; Claesson-Welsh L; Shimono A; Holmgren L
    Genes Dev; 2007 Aug; 21(16):2055-68. PubMed ID: 17699752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiomotin-like protein 1 controls endothelial polarity and junction stability during sprouting angiogenesis.
    Zheng Y; Vertuani S; Nyström S; Audebert S; Meijer I; Tegnebratt T; Borg JP; Uhlén P; Majumdar A; Holmgren L
    Circ Res; 2009 Jul; 105(3):260-70. PubMed ID: 19590046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiomotin: an angiostatin binding protein that regulates endothelial cell migration and tube formation.
    Troyanovsky B; Levchenko T; Månsson G; Matvijenko O; Holmgren L
    J Cell Biol; 2001 Mar; 152(6):1247-54. PubMed ID: 11257124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiomotin expression promotes hemangioendothelioma invasion.
    Levchenko T; Bratt A; Arbiser JL; Holmgren L
    Oncogene; 2004 Feb; 23(7):1469-73. PubMed ID: 14730344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of tecogalan sodium on angiogenesis in vitro by choroidal endothelial cells.
    Sakamoto T; Ishibashi T; Kimura H; Yoshikawa H; Spee C; Harris MS; Hinton DR; Ryan SJ
    Invest Ophthalmol Vis Sci; 1995 May; 36(6):1076-83. PubMed ID: 7537258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antivascular endothelial growth factor receptor (fetal liver kinase 1) monoclonal antibody inhibits tumor angiogenesis and growth of several mouse and human tumors.
    Prewett M; Huber J; Li Y; Santiago A; O'Connor W; King K; Overholser J; Hooper A; Pytowski B; Witte L; Bohlen P; Hicklin DJ
    Cancer Res; 1999 Oct; 59(20):5209-18. PubMed ID: 10537299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential roles of p80- and p130-angiomotin in the switch between migration and stabilization of endothelial cells.
    Ernkvist M; Birot O; Sinha I; Veitonmaki N; Nyström S; Aase K; Holmgren L
    Biochim Biophys Acta; 2008 Mar; 1783(3):429-37. PubMed ID: 18164266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-flt1 peptide, a vascular endothelial growth factor receptor 1-specific hexapeptide, inhibits tumor growth and metastasis.
    Bae DG; Kim TD; Li G; Yoon WH; Chae CB
    Clin Cancer Res; 2005 Apr; 11(7):2651-61. PubMed ID: 15814646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HGF/NK4 inhibited VEGF-induced angiogenesis in in vitro cultured endothelial cells and in vivo rabbit model.
    Nakabayashi M; Morishita R; Nakagami H; Kuba K; Matsumoto K; Nakamura T; Tano Y; Kaneda Y
    Diabetologia; 2003 Jan; 46(1):115-23. PubMed ID: 12637990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A DNA vaccine targeting angiomotin inhibits angiogenesis and suppresses tumor growth.
    Holmgren L; Ambrosino E; Birot O; Tullus C; Veitonmäki N; Levchenko T; Carlson LM; Musiani P; Iezzi M; Curcio C; Forni G; Cavallo F; Kiessling R
    Proc Natl Acad Sci U S A; 2006 Jun; 103(24):9208-13. PubMed ID: 16754857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined anti-fetal liver kinase 1 monoclonal antibody and continuous low-dose doxorubicin inhibits angiogenesis and growth of human soft tissue sarcoma xenografts by induction of endothelial cell apoptosis.
    Zhang L; Yu D; Hicklin DJ; Hannay JA; Ellis LM; Pollock RE
    Cancer Res; 2002 Apr; 62(7):2034-42. PubMed ID: 11929822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcription factor Egr-1 supports FGF-dependent angiogenesis during neovascularization and tumor growth.
    Fahmy RG; Dass CR; Sun LQ; Chesterman CN; Khachigian LM
    Nat Med; 2003 Aug; 9(8):1026-32. PubMed ID: 12872165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of glioblastoma angiogenesis and invasion by combined treatments directed against vascular endothelial growth factor receptor-2, epidermal growth factor receptor, and vascular endothelial-cadherin.
    Lamszus K; Brockmann MA; Eckerich C; Bohlen P; May C; Mangold U; Fillbrandt R; Westphal M
    Clin Cancer Res; 2005 Jul; 11(13):4934-40. PubMed ID: 16000592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct role of fibroblast growth factor-2 and vascular endothelial growth factor on tumor growth and angiogenesis.
    Giavazzi R; Sennino B; Coltrini D; Garofalo A; Dossi R; Ronca R; Tosatti MP; Presta M
    Am J Pathol; 2003 Jun; 162(6):1913-26. PubMed ID: 12759248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum response factor is a critical requirement for VEGF signaling in endothelial cells and VEGF-induced angiogenesis.
    Chai J; Jones MK; Tarnawski AS
    FASEB J; 2004 Aug; 18(11):1264-6. PubMed ID: 15180964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of afadin in vascular endothelial growth factor- and sphingosine 1-phosphate-induced angiogenesis.
    Tawa H; Rikitake Y; Takahashi M; Amano H; Miyata M; Satomi-Kobayashi S; Kinugasa M; Nagamatsu Y; Majima T; Ogita H; Miyoshi J; Hirata K; Takai Y
    Circ Res; 2010 Jun; 106(11):1731-42. PubMed ID: 20413783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of responsiveness to chemotactic factors by deletion of the C-terminal protein interaction site of angiomotin.
    Levchenko T; Aase K; Troyanovsky B; Bratt A; Holmgren L
    J Cell Sci; 2003 Sep; 116(Pt 18):3803-10. PubMed ID: 12902404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of neovascularization by human neutrophil peptides (alpha-defensins): a link between inflammation and angiogenesis.
    Chavakis T; Cines DB; Rhee JS; Liang OD; Schubert U; Hammes HP; Higazi AA; Nawroth PP; Preissner KT; Bdeir K
    FASEB J; 2004 Aug; 18(11):1306-8. PubMed ID: 15208269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin II type 2 receptor inhibits vascular endothelial growth factor-induced migration and in vitro tube formation of human endothelial cells.
    Benndorf R; Böger RH; Ergün S; Steenpass A; Wieland T
    Circ Res; 2003 Sep; 93(5):438-47. PubMed ID: 12881481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.